{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:38:11Z","timestamp":1789799891367,"version":"4.0.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The Hemoglobin, Albumin, Lymphocyte, and Platelet score (HALP) is an inflammatory nutrition-related biomarker based on hemoglobin and albumin levels, as well as the lymphocyte and platelet load index, which has been reported to be associated with the prognosis of various types of tumors. This study aims to investigate the prognostic value of HALP in patients with non-small cell lung cancer (NSCLC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 2,428 patients with NSCLC were enrolled in the INSCOC study. Time-patient survival trends were validated using Kaplan\u2013Meier curves and log-rank tests. The Restricted Cubic Spline function was used to analyze the relationship between the HALP index and overall survival (OS). The Cox regression model was used for univariate and multivariate analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included 2,053 patients with detailed biological information and follow-up data, consisting of 1,346 men (65.6%) and 707 women (34.4%). Within this cohort, 138 patients (6.7%) had stage I disease, 282 (13.7%) had stage II, 477 (23.2%) had stage III, and 1,156 (56.3%) had stage IV. A total of 536 patients (26.1%) underwent surgery, 1,494 (72.8%) received chemotherapy, and 271 (13.2%) received radiotherapy. The 1-, 2-, 3-, and 5-year survival rates for patients with NSCLC were 68.6, 48.6, 37.4, and 30.9%, respectively. The optimal cut-off for HALP was determined to be 29.71, with a sensitivity of 53.1% and specificity of 62.9%, leading to the categorization of patients into low (&amp;lt;29.71) (<jats:italic>n<\/jats:italic>\u202f=\u202f963) and high (\u226529.71) (<jats:italic>n<\/jats:italic>\u202f=\u202f1,090) HALP groups. Patients with a high HALP demonstrated a significantly higher 5-year overall survival (OS) rate compared to those with a low HALP (38% vs. 23%, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001). Multivariable Cox proportional hazards regression analysis identified that low HALP was an independent risk factor for the survival of patients with non-small cell lung cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The HALP index can be used as an independent prognostic factor for patients with NSCLC, offering clinicians a reference to identify high-risk patient with poor long-term prognoses and improve individualized treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2024.1428950","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:21:35Z","timestamp":1732767695000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["The preoperative hemoglobin, albumin, lymphocyte, and platelet score (HALP) as a prognostic indicator in patients with non-small cell lung cancer"],"prefix":"10.3389","volume":"11","author":[{"given":"Qiteng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3760\/cma.j.cn112152-20220922-00647","article-title":"Cancer statistics in China, 2016","volume":"45","author":"Zheng","year":"2023","journal-title":"Zhonghua zhong liu za zhi [Chinese J Oncol]"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1186\/s12885-022-10145-x","article-title":"Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Cancer"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.clnu.2022.04.019","article-title":"Inflammatory burden as a prognostic biomarker for cancer","volume":"41","author":"Xie","year":"2022","journal-title":"Clin Nutr"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.clnu.2023.02.021","article-title":"Nutrition impact symptoms: noteworthy prognostic indicators for lung cancer","volume":"42","author":"Liu","year":"2023","journal-title":"Clin Nutr"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ijc.34012","article-title":"C-reactive protein trajectories and the risk of all cancer types: a prospective cohort study","volume":"151","author":"Liu","year":"2022","journal-title":"Int J Cancer"},{"key":"ref7","first-page":"283","article-title":"Prognostic significance of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients undergoing curative resection for colorectal cancer","volume":"92","author":"Yalav","year":"2021","journal-title":"Ann Ital Chir"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"41370","DOI":"10.18632\/oncotarget.5629","article-title":"Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.17305\/bjbms.2021.5666","article-title":"The preoperative hemoglobin, albumin, lymphocyte and platelet (HALP) score is a useful predictor in patients with resectable esophageal squamous cell carcinoma","volume":"21","author":"Feng","year":"2021","journal-title":"Bosn J Basic Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3748\/wjg.v26.i8.828","article-title":"Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer","volume":"26","author":"Xu","year":"2020","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e00014","DOI":"10.1097\/pn9.0000000000000014","article-title":"Extension protocol for the investigation on nutrition status and clinical outcome of patients with common cancers in China (INSCOC) study: 2021 update","volume":"1","author":"Xu","year":"2022","journal-title":"Precis Nutr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/pn9.0000000000000008","article-title":"Cancer cachexia statistics in China","volume":"1","author":"Li","year":"2022","journal-title":"Precis Nutr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7150\/jca.27210","article-title":"The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel significant prognostic factor for patients with metastatic prostate Cancer undergoing cytoreductive radical prostatectomy","volume":"10","author":"Guo","year":"2019","journal-title":"J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3892\/mco.2021.2221","article-title":"Baseline anemia and anemia grade are independent prognostic factors for stage IV non-small cell lung cancer","volume":"14","author":"Chen","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.acuro.2020.04.005","article-title":"Impact of anemia on the survival of patients undergoing radical cystectomy for bladder cancer","volume":"44","author":"Ferran-Carpintero","year":"2020","journal-title":"Actas Urologicas Espanolas"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/carcin\/bgu247","article-title":"Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer","volume":"36","author":"Liu","year":"2015","journal-title":"Carcinogenesis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s12905-023-02713-5","article-title":"The effect of albumin and hemoglobin levels on the prognosis of early-stage cervical cancer: a prospective, single-center-based cohort study","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Womens Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1101\/2024.03.01.583044","article-title":"Inflammation promotes aging-associated oncogenesis in the lung","author":"Pham-Danis","year":"2024","journal-title":"bioRxiv"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/bs.pmbts.2022.10.002","article-title":"Role of lymphocytes, macrophages and immune receptors in suppression of tumor immunity","volume":"194","author":"Singh","year":"2023","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1200\/jco.19.02446","article-title":"Long-term outcomes and retreatment among patients with previously treated, programmed death-ligand 1\u2013positive, advanced non\u2013small-cell lung cancer in the KEYNOTE-010 study","volume":"38","author":"Herbst","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e7232","DOI":"10.7717\/peerj.7232","article-title":"Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancer","volume":"7","author":"Lohinai","year":"2019","journal-title":"PeerJ"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.lungcan.2021.11.021","article-title":"Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer","volume":"163","author":"Bryant","year":"2022","journal-title":"Lung Cancer"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.intimp.2017.02.027","article-title":"The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma","volume":"46","author":"Cong","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e0163523","DOI":"10.1371\/journal.pone.0163523","article-title":"Elevated platelet to lymphocyte ratio is associated with poor survival outcomes in patients with colorectal cancer","volume":"11","author":"Gu","year":"2016","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e101119","DOI":"10.1371\/journal.pone.0101119","article-title":"Prognostic value of PLR in various cancers: a meta-analysis","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"905292","DOI":"10.3389\/fnut.2022.905292","article-title":"HALP score and GNRI: simple and easily accessible indexes for predicting prognosis in advanced stage NSCLC patients. The \u0130zmir oncology group (IZOG) study","volume":"9","author":"G\u00fc\u00e7","year":"2022","journal-title":"Front Nutr"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"112191","DOI":"10.1016\/j.nut.2023.112191","article-title":"Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer","volume":"116","author":"Zhang","year":"2023","journal-title":"Nutrition"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijrobp.2005.04.049","article-title":"Anemia, tumor hypoxemia, and the cancer patient","volume":"63","author":"Varlotto","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"7606128","DOI":"10.1155\/2019\/7606128","article-title":"Preoperative anemia or low hemoglobin predicts poor prognosis in gastric cancer patients: a meta-analysis","volume":"2019","author":"Huang","year":"2019","journal-title":"Dis Markers"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/sj.bjc.6601886","article-title":"The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases","volume":"91","author":"al-Shaiba","year":"2004","journal-title":"Br J Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/1471-2407-14-542","article-title":"Identification of prognostic inflammatory factors in colorectal liver metastases","volume":"14","author":"Hamilton","year":"2014","journal-title":"BMC Cancer"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1042\/bst20180159","article-title":"Platelets in cancer development and diagnosis","volume":"46","author":"Contursi","year":"2018","journal-title":"Biochem Soc Trans"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12890-020-1139-5","article-title":"Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis","volume":"20","author":"Yuan","year":"2020","journal-title":"BMC Pulm Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00384-021-03950-6","article-title":"Prediction of the postoperative 90-day mortality after acute colorectal cancer surgery: development and temporal validation of the ACORCA model","volume":"36","author":"Degett","year":"2021","journal-title":"Int J Color Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia","volume":"11","author":"Peixoto da Silva","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1428950\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:21:38Z","timestamp":1732767698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1428950\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":36,"alternative-id":["10.3389\/fnut.2024.1428950"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2024.1428950","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"article-number":"1428950"}}